Patents by Inventor Elliot I. Stupak

Elliot I. Stupak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stabilized antihistamine syrup
    Patent number: 6939550
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: September 6, 2005
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Stabilized antihistamine syrup
    Publication number: 20030152595
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: November 15, 2002
    Publication date: August 14, 2003
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Stabilized antihistamine syrup
    Patent number: 6514520
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: February 4, 2003
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Stabilized antihistamine syrup
    Publication number: 20020132805
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: July 5, 2001
    Publication date: September 19, 2002
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Orally administrable solid ribavirin dosage forms and process for making them
    Patent number: 6337090
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin and a process for making such solid dosage forms are disclosed.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: January 8, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Orally administrable solid dosage form
    Patent number: 6335032
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: January 1, 2002
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Stabilized antihistamine syrup
    Patent number: 6132758
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of and about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid such as a salt of ethylenediaminetetraacetic acid.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: October 17, 2000
    Assignee: Schering Corporation
    Inventors: Farah J. Munayyer, Frank Guazzo, Elliot I. Stupak, Imtiaz A. Chaudry, Joel A. Sequeira
  • Orally administrable solid dosage form
    Patent number: 6051252
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is subsantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: April 18, 2000
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Process of making solid ribavirin dosage forms
    Patent number: 5916594
    Abstract: A process of making an orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin as determined is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 29, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen
  • Orally administrable solid dosage form
    Patent number: 5914128
    Abstract: An orally administrable solid dosage form containing a compacted ribavirin composition having an advantageously high tap density of at least 0.6 g/mL as well as surprisingly rapid disintegration and dissolution rates and wherein the ribavirin is substantially free of polymorphic forms of ribavirin is disclosed.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 22, 1999
    Assignee: Schering Corporation
    Inventors: Stephen M. Liebowitz, Elliot I. Stupak, Imtiaz A. Chaudry, Winston A. Vadino, Frank E. Bowen